GlassScriptPhysician profile
Melissa K Bailey
NPI 1558346098
$6,291.74
in general payments reported to CMS, 2019-2025
31 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $240 · 2021: $587 · 2022: $703 · 2023: $1,688 · 2024: $769 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,328 · Education: $631 · Travel and Lodging: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,327.84 |
| Education | $630.99 |
| Travel and Lodging | $573.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,773.07 | 2023-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $628.64 | 2023-2025 | Veozah |
| Abbvie INC. | $596.34 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Millicent US INC | $442.46 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Exeltis, USA INC. | $376.76 | 2020-2025 | Slynd |
| Pfizer INC. | $309.05 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $288.19 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $229.67 | 2021-2025 | |
| Coopersurgical, INC. | $222.84 | 2021-2025 | Ally II Ups, Supercut Hysterectomy Scissors |
| Therapeuticsmd, INC. | $162.91 | 2019-2022 | |
| Hologic Sales and Service, LLC | $152.15 | 2020-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Organon LLC | $141.32 | 2021-2025 | Nexplanon |
| Ascend Therapeutics US, LLC | $131.00 | 2021-2023 | |
| Avion Pharmaceuticals | $123.76 | 2019-2022 | |
| Agile Therapeutics, INC. | $123.34 | 2021-2024 | Twirla |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $87.43 | 2025 | Zurzuvae |
| Baxter Healthcare | $72.18 | 2022-2025 | Tisseel |
| Myovant Sciences INC. | $64.72 | 2021-2022 | |
| Minerva Surgical, INC | $61.58 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.63 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $36.10 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.33 | 2019-2021 | |
| Allergan, INC. | $28.69 | 2020 | |
| Integra Lifesciences Corporation | $27.22 | 2022-2024 | Biofix, Biodfactor, Biodoptix |
| Lupin INC. | $26.75 | 2020-2021 | |
| Abbott Laboratories | $23.94 | 2021 | |
| Mission Pharmacal Company | $23.00 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.41 | 2025 | Qelbree |
| Duchesnay USA Incorporated | $16.63 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.08 | 2020 | |
| Avanos Medical | $14.55 | 2023 | Standard Rf Disposables |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.